Press Releases

Contraceptives Market is estimated to expand at a CAGR of 15.5% from 2022 to 2030

Share This Article

Contraceptives Market Outlook 2028

The global contraceptives market was valued at US$ 893.9 Mn in 2020

It is estimated to expand at a CAGR of 15.5% from 2021 to 2028

The global contraceptives market is expected to cross the value of US$ 2.7 Bn by the end of 2028

Get the sample copy of report@ https://qyresearchmedical.com/sample/111484

Analysts’ Viewpoint on Contraceptives Market Scenario

Birth spacing methods amid the ongoing COVID-19 pandemic include precise advice on lactation amenorrhoea method (LAM) to enhance its efficacy, barrier methods such as condoms, and plentiful supplies of oral progestin-only pill, among others. The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players. Since there is a lack of awareness about the advantages of contraceptives in developing economies, market stakeholders should initiate collaborative agreements with governments to educate women as well as related individuals about different alternatives. Manufacturers should increase the production of affordable contraceptive options to boost their uptake in developing economies.

High Prevalence of Sexually Transmitted Infections Propels Demand for Contraceptives

A number of international and national organizations have initiated STI (sexually transmitted infections) awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

View full report@ https://qyresearchmedical.com/report/contraceptives-market-product-contraceptive-drugs-oral-contraceptives-contraceptive-injectable-and-topical-contraceptive-patch-and-contraceptive-devices-male-contraceptive-devices-and-female-contraceptive-dev-2021-2028/111484

Birth Spacing Helps Reduce Burden on Healthcare Systems amid COVID-19 Pandemic

The COVID-19 pandemic has heightened the importance for family planning since most people have been spending time indoors. Manufacturers in the contraceptives market are capitalizing on this opportunity to ensure uninterrupted supply of oral contraceptives, contraceptive injectables, and contraceptive devices. Healthcare organizations are stressing on the advantages of birth spacing during the ongoing pandemic, since avoiding pregnancy during such uncertain times is wise for women not only on a personal level but also from a public health perspective in terms of not adding to overburdened healthcare systems. Manufacturers are increasing efforts to prevent stock-outs for implants, oral contraceptive pills, and copper intrauterine devices.

Comprehensive Product Portfolio Allows Stakeholders to Expand Income Sources

The contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the market.

Oral (pill) contraceptives, topical contraceptives, and injectable contraceptives are various types of contraceptives. Contraceptive devices, on the other hand, include condoms, intrauterine devices (IUD), vaginal rings, implants, patches, diaphragms, sponges, etc. The barrier method, particularly condoms, is the most common form of artificial contraception.

The global contraceptives market is expected to be driven by increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111484/2900

Lack of Knowledge about Advantages of Contraceptives Hampers Market Growth

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average. In Asia, majority of unintended pregnancies is caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion.

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in this market. Hence, participants in the market should collaborate with governments to increase awareness about the advantages of contraceptives, which holds potential to boost product sales.

U.S. Sets Benchmark for Contraceptive Innovation and Collaborative Agreements

Key players in the global contraceptives market are engaged in regulatory approvals, innovations in technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are announcing the generic versions of vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.

Healthcare organizations are launching global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market. At the same time, manufacturers are investing in R&D to increase availability of FDA (Food and Drug Administration)-approved contraceptive options.

Contraceptives Market: Overview

According to Transparency Market Research’s latest report on the global contraceptives market for the historical period 2017–2018 and forecast period 2019–2027, decline in prices and increase in access to contraceptives are projected to drive the global contraceptives market during the forecast period

Rise in Prevalence of Sexually Transmitted Diseases Drives Demand for Contraceptive Tablets and Other Forms of Contraception

A number of international and national organizations have initiated STI awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

Increase in adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptives market. People across the world have become more aware about the need of family planning.

Entry of New Vendors with Advanced Contraceptive Methods: Key Driver

The global contraceptives market is likely to provide new vendors significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the global contraceptives market.

Lack of Awareness about Application of Contraceptive Devices in Emerging Countries

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average.

In Asia, majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in the global contraceptives market.

Competition Landscape

This report profiles major players in the global contraceptives market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments

The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players

Leading players operating in the global contraceptives market are

  • Merck & Co., Inc., Cipla, Inc.
  • Allergan plc
  • Bayer AG
  • HLL Lifecare Limited
  • Mankind Pharma
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mithra Pharmaceuticals
  • Janssen Pharmaceutical Company
  • Reckitt Benckiser Group plc., etc.

Key Developments

Key players in the global contraceptives market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptives market. A few expansion strategies adopted by players operating in the global contraceptives market are:

On January 14, 2021, Teva Pharmaceuticals announced the generic version of NuvaRing (etonogestrel and ethinyl estradiol) vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptives market.

On November 17, 2020, the World Health Organization launched global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market.

On May 22, 2020, Evofem Biosciences, Inc. announced that the U.S. Food and Drug Administration had approved Phexxi, a new contraceptive method

The report on the global contraceptives market discussed individual strategies, followed by company profiles of manufacturers of contraceptives devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global contraceptives market.

Key Questions Answered in Contraceptives Market Report

  • What is the scope of growth of product companies in the global contraceptives market?
  • What will be the Y-o-Y growth of the global contraceptives market between 2017 and 2028?
  • What is the influence of changing trends in technologies on the global contraceptives market?
  • Will North America to be the most profitable market for contraceptives devices providers?
  • Which factors are anticipated to hamper the growth of the global contraceptives market during the forecast period?
  • Which are the leading companies in the global contraceptives market?

Contraceptives Market – Segmentation

Product

  • Contraceptive Drugs
  • Oral Contraceptives
  • Combined Contraceptives
  • Mini-pills
  • Contraceptive Injectable
  • Topical Contraceptive Patch
  • Contraceptive Devices
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Tissue Engineering

Distribution Channel

  • Hospitals Pharmacy
  • Public
  • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others

Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

TABLE OF CONTENT

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Contraceptives Market

4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Key Market Indicators

4.4. Market Dynamics

4.4.1. Drivers

4.4.2. Restraints

4.4.3. Opportunity

4.5. Global Contraceptives Market Analysis and Forecast, 2017–2028

4.5.1. Market Revenue Projections (US$ Mn)

4.6. Global Contraceptives Market – Global Supply Demand Scenario

4.7. Porter’s Five Force Analysis

4.8. Value Chain Analysis

4.9. Market Outlook

5. Global Contraceptives Market Analysis and Forecast, By Product

5.1. Introduction & Definition

5.2. Key Findings / Developments

5.3. Key Trends

5.4. Market Value Forecast, by Product, 2017–2028

5.4.1. Contraceptives Drugs

5.4.1.1. Oral Contraceptives

5.4.1.1.1. Combined Contraceptives

5.4.1.1.2. Mini-pills

5.4.1.2. Contraceptive Injectable

5.4.1.3. Topical Contraceptive Patch

5.4.2. Contraceptive Devices

5.4.2.1. Male Contraceptive Devices

5.4.2.2. Female Contraceptive Devices

5.4.2.2.1. Female Condoms

5.4.2.2.2. Contraceptive Diaphragms

5.4.2.2.3. Contraceptive Sponges

5.4.2.2.4. Contraceptive Vaginal Rings

5.4.2.2.5. Intrauterine Devices

5.4.2.2.6. Sub-dermal Contraceptives Implants

5.4.2.2.7. Non-Surgical Permanent Contraception Devices

5.5. Market Attractiveness Analysis, By Product

6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

6.1. Introduction & Definition

6.2. Key Findings / Developments

6.3. Key Trends

6.4. Market Value Forecast, by Distribution Channel, 2017–2028

6.4.1. Hospital Pharmacy

6.4.1.1. Public

6.4.1.2. Private

6.4.2. Independent Pharmacy

6.4.3. Online Platform

6.4.4. Clinics

6.4.5. Others

6.5. Market Attractiveness Analysis, By Distribution Channel

7. Global Contraceptives Market Analysis and Forecast, By Region

7.1. Key Findings

7.2. Policies and Regulations

7.3. Market Value Forecast, by Region

7.3.1. North America

7.3.2. Europe

7.3.3. Asia Pacific

7.3.4. Latin America

7.3.5. Middle East and Africa

7.4. Market Attractiveness Analysis, By Country/Region

8. North America Contraceptives Market Analysis and Forecast

8.1. Introduction

8.1.1. Key Findings

8.1.2. Policies and Regulations

8.1.3. Key Trends

8.2. Market Value Forecast, by Product, 2017–2028

8.2.1. Contraceptive Drugs

8.2.1.1. Oral Contraceptives

8.2.1.1.1. Combined Contraceptives

8.2.1.1.2. Mini-pills

8.2.1.2. Contraceptive Injectable

8.2.1.3. Topical Contraceptive Patch

8.2.2. Contraceptive Devices

8.2.2.1. Male Contraceptive Devices

8.2.2.2. Female Contraceptive Devices

8.2.2.2.1. Female Condoms

8.2.2.2.2. Contraceptive Diaphragms

8.2.2.2.3. Contraceptive Sponges

8.2.2.2.4. Contraceptive Vaginal Rings

8.2.2.2.5. Intrauterine Devices

8.2.2.2.6. Sub-dermal Contraceptives Implants

8.2.2.2.7. Non-Surgical Permanent Contraception Devices

8.3. Market Value Forecast, by Distribution Channel, 2017–2028

8.3.1. Hospital Pharmacy

8.3.1.1. Public

8.3.1.2. Private

8.3.2. Independent Pharmacy

8.3.3. Online Platform

8.3.4. Clinics

8.3.5. Others

8.4. Market Value Forecast, by Country, 2017–2028

8.4.1. U.S.

8.4.2. Canada

8.5. Market Attractiveness Analysis

8.5.1. By Product

8.5.2. By Distribution Channel

8.5.3. By Country

9. Europe Contraceptives Market Analysis and Forecast

9.1. Introduction

9.1.1. Key Findings

9.1.2. Policies and Regulations

9.1.3. Key Trends

9.2. Market Value Forecast, by Product, 2017–2028

9.2.1. Contraceptive Drugs

9.2.1.1. Oral Contraceptives

9.2.1.1.1. Combined Contraceptives

9.2.1.1.2. Mini-pills

9.2.1.2. Contraceptive Injectable

9.2.1.3. Topical Contraceptive Patch

9.2.2. Contraceptive Devices

9.2.2.1. Male Contraceptive Devices

9.2.2.2. Female Contraceptive Devices

9.2.2.2.1. Female Condoms

9.2.2.2.2. Contraceptive Diaphragms

9.2.2.2.3. Contraceptive Sponges

9.2.2.2.4. Contraceptive Vaginal Rings

9.2.2.2.5. Intrauterine Devices

9.2.2.2.6. Sub-dermal Contraceptives Implants

9.2.2.2.7. Non-Surgical Permanent Contraception Devices

9.3. Market Value Forecast, by Distribution Channel, 2017–2028

9.3.1. Hospital Pharmacy

9.3.1.1. Public

9.3.1.2. Private

9.3.2. Independent Pharmacy

9.3.3. Online Platform

9.3.4. Clinics

9.3.5. Others

9.4. Market Value Forecast, by Country/Sub-region, 2017–2028

9.4.1. Germany

9.4.2. France

9.4.3. U.K.

9.4.4. Spain

9.4.5. Italy

9.4.6. Russia

9.4.7. Rest of Europe

9.5. Market Attractiveness Analysis

9.5.1. By Product

9.5.2. By Distribution Channel

9.5.3. By Country/Sub-region

10. Asia Pacific Contraceptives Market Analysis and Forecast

10.1. Introduction

10.1.1. Key Findings

10.1.2. Policies and Regulations

10.1.3. Key Trends

10.2. Market Value Forecast, by Product, 2017–2028

10.2.1. Contraceptive Drugs

10.2.1.1. Oral Contraceptives

10.2.1.1.1. Combined Contraceptives

10.2.1.1.2. Mini-pills

10.2.1.2. Contraceptive Injectable

10.2.1.3. Topical Contraceptive Patch

10.2.2. Contraceptive Devices

10.2.2.1. Male Contraceptive Devices

10.2.2.2. Female Contraceptive Devices

10.2.2.2.1. Female Condoms

10.2.2.2.2. Contraceptive Diaphragms

10.2.2.2.3. Contraceptive Sponges

10.2.2.2.4. Contraceptive Vaginal Rings

10.2.2.2.5. Intrauterine Devices

10.2.2.2.6. Sub-dermal Contraceptives Implants

10.2.2.2.7. Non-Surgical Permanent Contraception Devices

10.3. Market Value Forecast, by Distribution Channel, 2017–2028

10.3.1. Hospital Pharmacy

10.3.1.1. Public

10.3.1.2. Private

10.3.2. Independent Pharmacy

10.3.3. Online Platforms

10.3.4. Clinics

10.3.5. Others

10.4. Market Value Forecast, by Country/Sub-region, 2017–2028

10.4.1. China

10.4.2. Japan

10.4.3. India

10.4.4. Australia & New Zealand

10.4.5. Rest of Asia Pacific

10.5. Market Attractiveness Analysis

10.5.1. By Product

10.5.2. By Distribution Channel

10.5.3. By Country/Sub-region

11. Latin America Contraceptives Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.1.2. Policies and Regulations

11.1.3. Key Trends

11.2. Market Value Forecast, by Product, 2017–2028

11.2.1. Contraceptive Drugs

11.2.1.1. Oral Contraceptives

11.2.1.1.1. Combined Contraceptives

11.2.1.1.2. Mini-pills

11.2.1.2. Contraceptive Injectable

11.2.1.3. Topical Contraceptive Patch

11.2.2. Contraceptive Devices

11.2.2.1. Male Contraceptive Devices

11.2.2.2. Female Contraceptive Devices

11.2.2.2.1. Female Condoms

11.2.2.2.2. Contraceptive Diaphragms

11.2.2.2.3. Contraceptive Sponges

11.2.2.2.4. Contraceptive Vaginal Rings

11.2.2.2.5. Intrauterine Devices

11.2.2.2.6. Sub-dermal Contraceptives Implants

11.2.2.2.7. Non-Surgical Permanent Contraception Devices

11.3. Market Value Forecast, by Distribution Channel, 2017–2028

11.3.1. Hospital Pharmacy

11.3.1.1. Public

11.3.1.2. Private

11.3.2. Independent Pharmacy

11.3.3. Online Platforms

11.3.4. Clinics

11.3.5. Others

11.4. Market Value Forecast, by Country/Sub-region, 2017–2028

11.4.1. Brazil

11.4.2. Mexico

11.4.3. Rest of Latin America

11.5. Market Attractiveness Analysis

11.5.1. By Product

11.5.2. By Distribution Channel

11.5.3. By Country/Sub-region

12. Middle East and Africa Contraceptives Market Analysis and Forecast

12.1. Introduction

12.1.1. Key Findings

12.1.2. Policies and Regulations

12.1.3. Key Trends

12.2. Market Value Forecast, by Product, 2017–2028

12.2.1. Contraceptive Drugs

12.2.1.1. Oral Contraceptives

12.2.1.1.1. Combined Contraceptives

12.2.1.1.2. Mini-pills

12.2.1.2. Contraceptive Injectable

12.2.1.3. Topical Contraceptive Patch

12.2.2. Contraceptive Devices

12.2.2.1. Male Contraceptive Devices

12.2.2.2. Female Contraceptive Devices

12.2.2.2.1. Female Condoms

12.2.2.2.2. Contraceptive Diaphragms

12.2.2.2.3. Contraceptive Sponges

12.2.2.2.4. Contraceptive Vaginal Rings

12.2.2.2.5. Intrauterine Devices

12.2.2.2.6. Sub-dermal Contraceptives Implants

12.2.2.2.7. Non-Surgical Permanent Contraception Devices

12.3. Market Value Forecast, by End User, 2017–2028

12.3.1. Hospital Pharmacy

12.3.1.1. Public

12.3.1.2. Private

12.3.2. Independent Pharmacy

12.3.3. Online Platform

12.3.4. Clinics

12.3.5. Others

12.4. Market Value Forecast, by Country /Sub-region, 2017–2028

12.4.1. GCC Countries

12.4.2. South Africa

12.4.3. Rest of Middle East and Africa

12.5. Market Attractiveness Analysis

12.5.1. By Product

12.5.2. By Distribution Channel

12.5.3. By Country/Sub-region

13. Competition Landscape

13.1. Market Player – Competition Matrix (by tier and size of companies)

13.2. Market Share Analysis, by Company, 2020

13.3. Company Profiles

13.3.1. Merck & Co., Inc.

13.3.1.1. Overview

13.3.1.2. Financials

13.3.1.3. Recent Developments

13.3.1.4. Strategy

13.3.2. Cipla, Inc.

13.3.2.1. Overview

13.3.2.2. Financials

13.3.2.3. Recent Developments

13.3.2.4. Strategy

13.3.3. Allergan plc

13.3.3.1. Overview

13.3.3.2. Financials

13.3.3.3. Recent Developments

13.3.3.4. Strategy

13.3.4. Bayer AG

13.3.4.1. Overview

13.3.4.2. Financials

13.3.4.3. Recent Developments

13.3.4.4. Strategy

13.3.5. HLL Lifecare Limited

13.3.5.1. Overview

13.3.5.2. Financials

13.3.5.3. Recent Developments

13.3.5.4. Strategy

13.3.6. Mankind Pharma

13.3.6.1. Overview

13.3.6.2. Financials

13.3.6.3. Recent Developments

13.3.6.4. Strategy

13.3.7. Pfizer, Inc.

13.3.7.1. Overview

13.3.7.2. Financials

13.3.7.3. Recent Developments

13.3.7.4. Strategy

13.3.8. Teva Pharmaceutical Industries Ltd.

13.3.8.1. Overview

13.3.8.2. Financials

13.3.8.3. Recent Developments

13.3.8.4. Strategy

13.3.9. Mithra Pharmaceuticals

13.3.9.1. Overview

13.3.9.2. Financials

13.3.9.3. Recent Developments

13.3.9.4. Strategy

13.3.10. Janssen Pharmaceutical Company

13.3.10.1. Overview

13.3.10.2. Financials

13.3.10.3. Recent Developments

13.3.10.4. Strategy

13.3.11. Reckitt Benckiser Group plc

13.3.11.1. Overview

13.3.11.2. Financials

13.3.11.3. Recent Developments

13.3.11.4. Strategy

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111484/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi

Related Articles

Back to top button